Fonte: European Journal of Clinical Microbiology & Infectious Diseases. Unidades: FMRP, FCFRP
Assuntos: BACTÉRIAS, ANTIBIÓTICOS
ABNT
ABICHABKI, Nathália de Lima Martins et al. Ceftazidime-avibactam tolerance and persistence among difficult-to-treat KPC-producing Klebsiella pneumoniae clinical isolates from bloodstream infections. European Journal of Clinical Microbiology & Infectious Diseases, v. 44, n. 2, p. 343-353, 2025Tradução . . Disponível em: https://doi.org/10.1007/s10096-024-05005-4. Acesso em: 08 out. 2025.APA
Abichabki, N. de L. M., Gaspar, G. G., Bortolato, L. R., Lima, D. A. F. dos S., Silva, L. N., Pocente, R. H. C., et al. (2025). Ceftazidime-avibactam tolerance and persistence among difficult-to-treat KPC-producing Klebsiella pneumoniae clinical isolates from bloodstream infections. European Journal of Clinical Microbiology & Infectious Diseases, 44( 2), 343-353. doi:10.1007/s10096-024-05005-4NLM
Abichabki N de LM, Gaspar GG, Bortolato LR, Lima DAF dos S, Silva LN, Pocente RHC, Ferreira JC, Ogasawara TMC, Pereira D, Guerra RR, Wilhelm C, Barth P, Martins AF, Barth A, Braga GUL, De Martinis ECP, Bengtsson-Palme J, Bellissimo-Rodrigues F, Bollela VR, Darini AL da C, Andrade LN de. Ceftazidime-avibactam tolerance and persistence among difficult-to-treat KPC-producing Klebsiella pneumoniae clinical isolates from bloodstream infections [Internet]. European Journal of Clinical Microbiology & Infectious Diseases. 2025 ; 44( 2): 343-353.[citado 2025 out. 08 ] Available from: https://doi.org/10.1007/s10096-024-05005-4Vancouver
Abichabki N de LM, Gaspar GG, Bortolato LR, Lima DAF dos S, Silva LN, Pocente RHC, Ferreira JC, Ogasawara TMC, Pereira D, Guerra RR, Wilhelm C, Barth P, Martins AF, Barth A, Braga GUL, De Martinis ECP, Bengtsson-Palme J, Bellissimo-Rodrigues F, Bollela VR, Darini AL da C, Andrade LN de. Ceftazidime-avibactam tolerance and persistence among difficult-to-treat KPC-producing Klebsiella pneumoniae clinical isolates from bloodstream infections [Internet]. European Journal of Clinical Microbiology & Infectious Diseases. 2025 ; 44( 2): 343-353.[citado 2025 out. 08 ] Available from: https://doi.org/10.1007/s10096-024-05005-4